Correction: Camptothecin suppresses NRF2–ARE activity and sensitises hepatocellular carcinoma cells to anticancer drugs (British Journal of Cancer, (2017), 117, 10, (1495-1506), 10.1038/bjc.2017.317) | |
Chen F.; Wang H.; Zhu J.; Zhao R.; Xue P.; Zhang Q.; Nelson M.B.; Qu W.; 等 更多 | |
刊名 | British Journal of Cancer |
2019 | |
DOI | 10.1038/s41416-019-0527-1 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4546360 |
专题 | 山东大学 |
作者单位 | Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, |
推荐引用方式 GB/T 7714 | Chen F.,Wang H.,Zhu J.,et al. Correction: Camptothecin suppresses NRF2–ARE activity and sensitises hepatocellular carcinoma cells to anticancer drugs (British Journal of Cancer, (2017), 117, 10, (1495-1506), 10.1038/bjc.2017.317)[J]. British Journal of Cancer,2019. |
APA | Chen F..,Wang H..,Zhu J..,Zhao R..,Xue P..,...&等 更多.(2019).Correction: Camptothecin suppresses NRF2–ARE activity and sensitises hepatocellular carcinoma cells to anticancer drugs (British Journal of Cancer, (2017), 117, 10, (1495-1506), 10.1038/bjc.2017.317).British Journal of Cancer. |
MLA | Chen F.,et al."Correction: Camptothecin suppresses NRF2–ARE activity and sensitises hepatocellular carcinoma cells to anticancer drugs (British Journal of Cancer, (2017), 117, 10, (1495-1506), 10.1038/bjc.2017.317)".British Journal of Cancer (2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论